文献速递心胸血管麻醉术前评估与围术期医学

心脏手术术前贫血与术后结局:术中输血中介效应分析

Preoperative Anemia and Postoperative Outcomes in Cardiac Surgery: A Mediation Analysis Evaluating Intraoperative Transfusion Exposures.
PubMed 文献 · Anesth Analg · 2024-02-09

该历史性观察队列纳入2008至2018年4117例体外循环下冠脉搭桥或瓣膜手术成人,术前贫血1234例(30%)。术前贫血与术后急性肾损伤(AKI)风险升高相关,该关联主要来自贫血直接效应,而非术中红细胞输注中介;术前贫血还与住院时间延长相关,其中38%效应由术中输血中介。

要点

  • 术前贫血与心脏术后AKI风险升高独立相关,直接效应为主。
  • 术前血红蛋白越低,术后AKI风险越高。
  • 术前贫血延长住院时间,部分由术中红细胞输注中介。

核心结论

  • 术前贫血与心脏手术后AKI风险升高及住院时间延长相关。
  • 贫血与输血对术后并发症的归因效应可能因结局不同而异。

研究设计与样本

  • 历史性观察队列研究,纳入2008年5月1日至2018年5月1日单中心体外循环下冠脉搭桥或瓣膜手术成人4117例。
  • 采用中介分析框架评估术前贫血与术后结局关联,术中红细胞输注作为中介变量。

主要发现

  • 4117例中1234例(30%)存在术前贫血;437例(11%)发生AKI,贫血组219/1234(18%)高于非贫血组218/2883(8%)。
  • 术前贫血与术后AKI绝对差异6.4%(95%CI 4.2%-8.7%,P<.001)。
  • 术前血红蛋白9 g/dL较参考14 g/dL的AKI概率绝对增加11.9%(95%CI 6.9%-17.5%,P<.001)。
  • 术前贫血与AKI关联主要由直接效应介导(绝对差异5.9%,95%CI 3.6%-8.3%,P<.001),经输血中介仅占总效应7.5%(95%CI -4.3%至21.1%,P=.220)。
  • 术前贫血与住院时间几何均值比1.07(95%CI 1.05-1.10,P<.001),其中38%(95%CI 22%-62%,P<.001)估计经术中红细胞输注中介。

临床怎么用

  • 心脏术前应识别并评估贫血,将其视为术后AKI和住院延长的风险因素。
  • 减少术中输血可能不足以完全消除贫血相关AKI风险,需关注贫血直接机制。

局限性

  • 单中心历史性观察队列,中介分析结果需未来研究验证贫血相关术后器官损伤机制及治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative anemia is associated with adverse outcomes in cardiac surgery, yet it remains unclear what proportion of this association is mediated through red blood cell (RBC) transfusions. METHODS: This is a historical observational cohort study of adults undergoing coronary artery bypass grafting or valve surgery on cardiopulmonary bypass at an academic medical center between May 1, 2008, and May 1, 2018. A mediation analysis framework was used to evaluate the associations between preoperative anemia and postoperative outcomes, including a primary outcome of acute kidney injury (AKI). Intraoperative RBC transfusions were evaluated as mediators of preoperative anemia and outcome relationships. The estimated total effect, average direct effect of preoperative anemia, and percent of the total effect mediated through transfusions are presented with 95% confidence intervals and P -values. RESULTS: A total of 4117 patients were included, including 1234 (30%) with preoperative anemia. Overall, 437 of 4117 (11%) patients went on to develop AKI, with a greater proportion of patients having preoperative anemia (219 of 1234 [18%] vs 218 of 2883 [8%]). In multivariable analyses, the presence of preoperative anemia was associated with increased postoperative AKI (6.4% [4.2%-8.7%] absolute difference in percent with AKI, P < .001), with incremental decreases in preoperative hemoglobin concentrations displaying greater AKI risk (eg, 11.9% [6.9%-17.5%] absolute increase in probability of AKI for preoperative hemoglobin of 9 g/dL compared to a reference of 14 g/dL, P < .001). The association between preoperative anemia and postoperative AKI was primarily due to direct effects of preoperative anemia (5.9% [3.6%-8.3%] absolute difference, P < .001) rather than mediated through intraoperative RBC transfusions (7.5% [-4.3% to 21.1%] of the total effect mediated by transfusions, P = .220). Preoperative anemia was also associated with longer hospital durations (1.07 [1.05-1.10] ratio of geometric mean length of stay, P < .001). Of this total effect, 38% (22%, 62%; P < .001) was estimated to be mediated through subsequent intraoperative RBC transfusion. Preoperative anemia was not associated with reoperation or vascular complications. CONCLUSIONS: Preoperative anemia was associated with higher odds of AKI and longer hospitalizations in cardiac surgery. The attributable effects of anemia and transfusion on postoperative complications are likely to differ across outcomes. Future studies are necessary to further evaluate mechanisms of anemia-associated postoperative organ injury and treatment strategies.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Warner MA, Hanson AC, Schulte PJ, et al. Preoperative Anemia and Postoperative Outcomes in Cardiac Surgery: A Mediation Analysis Evaluating Intraoperative Transfusion Exposures. Anesth Analg. 2024. PMID: 38335136. doi:10.1213/ANE.0000000000006765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。